Aktuelle Neuigkeiten

Aktuelle Neuigkeiten

Hauck & Aufh?user takes first step towards digital assets

2020-10-09

Investigational New Drug Application of Henlius SARS-CoV-2 Neutralizing Antibody HLX70 Approved by US FDA

2020-10-05

Henlius Released Phase 3 Study Data of its Bevacizumab Biosimilar HLX04 at CSCO 2020

2020-09-22

Opening of Hauck Investment Management (Shanghai) Co.

2020-09-22

Facilitating an Organisational Upgrade and Capitalising on European Opportunities

2020-09-21

WHO Adds Fosun Pharma’s Covid-19 Test to Its Emergency Use List

2020-09-11

Fosun successfully held FC2M Conference to expedite further industry operations development

2020-09-09

Fosun International’s HSI ESG rating upgraded, Selected as constituent of Hang Seng Corporate Sustainability Benchmark Index

2020-09-07

Fosun International improves MSCI ESG rating to grade A

2020-09-03

Fosun International Announces 2020 Interim Results Total revenue reaches RMB63.27 billion, demonstrating a rapid business recovery

2020-08-27

China’s First Trastuzumab Biosimilar 漢曲優? Approved by NMPA

2020-08-14

Peak Re named “Asian Reinsurer of the Year” for the fifth consecutive time

2020-08-07

Wolves brand named in football's top 20

2020-08-07

Challenge Dilemmas in The Treatment of SCCHN,?Henlius Innovative Combination Therapy Dosed The First Patient in A Phase 2 Clinical Trial?

2020-07-30

Guo Guangchang: The First Dose! The novel coronavirus mRNA vaccine has officially started the human clinical trial in China

2020-07-29

Fidelidade Macau Insurance Company donates 5,000 face masks to Caritas Macau

2020-07-23

Nuno wins Manager of the Month award | 10th July 2020

2020-07-21

Fosun Pharma Announces its Licensed COVID-19 Vaccine Product Receives Acceptance Notice of Clinical Trial Application by NMPA

2020-07-14
免费网站看黄页